This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
e.l.f. Beauty (ELF) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in e.l.f. Beauty (ELF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ELFNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Chipotle (CMG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Chipotle (CMG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CMGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Builders FirstSource (BLDR) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Builders FirstSource (BLDR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BLDRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is SoundHound AI (SOUN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in SoundHound AI (SOUN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SOUNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Marvell (MRVL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MRVLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Leidos (LDOS): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Leidos (LDOS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
LDOSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is The Trade Desk (TTD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for The Trade Desk (TTD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TTDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in JD.com (JD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JD.com (JD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
JDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in MasterCard (MA): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in MasterCard (MA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Li Auto (LI): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Li Auto (LI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Riot Platforms, Inc. (RIOT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Riot Platforms, Inc. (RIOT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RIOTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Petrobras (PBR) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Petrobras (PBR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PBRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UNHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think SkyWater Technology (SKYT) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), SkyWater Technology (SKYT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SKYTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Snowflake (SNOW) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Snowflake (SNOW) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SNOWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Nu (NU) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Nu (NU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Freeport-McMoRan (FCX) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Freeport-McMoRan (FCX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
FCXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Deere (DE) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Deere (DE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Chevron (CVX): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Chevron (CVX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Boeing (BA): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Boeing (BA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Lowe's (LOW) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Lowe's (LOW). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LOWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Zscaler (ZS) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Zscaler (ZS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ZSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Celsius (CELH): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celsius (CELH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CELHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ADMANo Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Uber (UBER) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Uber (UBER) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
UBERPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth